The following table provides a reconciliation of the weighted average number of shares outstanding used to compute basic and diluted EPS for the periods presented:


	Three Months Ended		Six Months Ended
(in millions)	July 3, 2026	July 4, 2025	July 3, 2026	July 4, 2025
Basic weighted average number of shares outstanding	126	129	126	129
Dilutive common share equivalents—stock options and other stock awards	—	1	1	1
Diluted weighted average number of shares outstanding	126	130	127	130

Anti-dilutive stock-based awards are excluded from the weighted average number of shares outstanding used to compute diluted EPS. The total outstanding stock options and vesting stock awards that were anti-dilutive were less than 1.0 million for the three and six months ended July 3, 2026, and less than 0.5 million for the three and six months ended July 4, 2025.

During the three and six months ended July 3, 2026, we made open market repurchases of our common stock for an aggregate purchase price of $66 million and $266 million, respectively. All repurchased shares were immediately retired. There were no open market repurchases during the three and six months ended July 4, 2025.

In fiscal 2025, we entered into an accelerated share repurchase agreement with a financial institution to repurchase shares of our outstanding common stock. We paid $500 million to the financial institution and received 3.6 million shares.